This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Epizyme, Inc.. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 530 
2 out of 159 
Years Active: 2020-2024
Title: Futoshi Shikata: Innovator in Cancer Treatment
Introduction
Futoshi Shikata is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer therapy through his innovative research and development. With a total of 2 patents, Shikata's work focuses on pharmaceutical compositions that target specific mechanisms in cancer cells.
Latest Patents
Shikata's latest patents include a method for treating cancer, which involves pharmaceutical compositions comprising inhibitors of human histone methyltransferase EZH2. This invention outlines methods of cancer therapy utilizing these EZH2 inhibitors, showcasing his commitment to advancing cancer treatment options.
Career Highlights
Throughout his career, Futoshi Shikata has worked with notable companies such as Epizyme, Inc. and Eisai R&D Management Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Shikata's coworkers include Heike Keilhack and Brett Truitt. Their collaborative efforts have further enhanced the impact of his research in cancer therapy.
Conclusion
Futoshi Shikata's innovative work in cancer treatment exemplifies the importance of research and development in the medical field. His contributions continue to pave the way for new therapeutic approaches to combat cancer effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile